Organigram Reports Third Quarter Fiscal 2021 Results
Grew gross revenue 51% sequentially to $29.1 million in Q3 2021 from Q2 2021 and 31% from the same prior
Read moreGrew gross revenue 51% sequentially to $29.1 million in Q3 2021 from Q2 2021 and 31% from the same prior
Read moreRevenue Increases 27% Year-over-Year to $28.3 Million, Driven By Continued Success in Penetrating Top MSOs, LPs, and Leading Brands CYPRESS,
Read moreVANCOUVER, BC / ACCESSWIRE / June 29, 2021 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis
Read moreCompany Expects Fiscal Q3 2021 Revenue to Increase 21% to 26% Year-Over-Year CYPRESS, CA / ACCESSWIRE / June 15, 2021
Read moreOTTAWA, June 14, 2021 (GLOBE NEWSWIRE) — HEXO Corp. (TSX: HEXO; NYSE: HEXO) (“HEXO” or the “Company”) today reported its
Read moreDomestic Medical Net Revenue Steady at $26.9 Million Strong International Medical Net Revenue of $9.4 Million Total Cannabis Net Revenue, Excluding Provisions,
Read moreThird quarter revenue of $32.0 million, up 3.8% from the previous quarter adjusting for removal of MedMen NY Inc. from
Read more